首页> 美国卫生研究院文献>Central Asian Journal of Global Health >Ectopic Liver Tissue Formation in Rats with Induced Liver Fibrosis
【2h】

Ectopic Liver Tissue Formation in Rats with Induced Liver Fibrosis

机译:诱导性肝纤维化大鼠的异位肝组织形成

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

IntroductionThe possible alternative approach to whole-organ transplantation is a cell-based therapy, which can also be used as a “bridge” to liver transplantation. However, morphological and functional changes in the liver of patients suffering from chronic liver fibrosis and cirrhosis restrict the effectiveness of direct cell transplantation. Therefore, extra hepatic sites for cell transplantation, including the spleen, pancreas, peritoneal cavity, and subrenal capsule, could be a useful therapeutic approach for compensation of liver functions. However, a method of transplantation of hepatocytes into ectopic sites is needed to improve hepatocyte engraftment. Previously published data has demonstrated that mouse lymph nodes can support the engraftment and proliferation of hepatocytes as ES and rescue Fah mice from lethal liver failure. Thus, the aim of the study was to evaluate the engraftment of i.p. injected allogeneic hepatocytes into extra hepatic sites in albino rats with chemically induced liver fibrosis (LF).
机译:引言全器官移植的可能替代方法是基于细胞的疗法,也可以用作肝移植的“桥梁”。然而,患有慢性肝纤维化和肝硬化的患者肝脏的形态和功能改变限制了直接细胞移植的有效性。因此,包括脾脏,胰脏,腹膜腔和肾下膜囊在内的肝移植部位可能是补偿肝功能的有用治疗方法。但是,需要一种将肝细胞移植到异位的方法来改善肝细胞的植入。先前发表的数据表明,小鼠淋巴结可以支持肝细胞作为ES的移植和增殖,并从致命的肝衰竭中拯救Fah小鼠。因此,该研究的目的是评估i.p.的植入。将同种异体肝细胞注射到患有化学性肝纤维化(LF)的白化病大鼠的肝外部位。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号